Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. MedSci Healthcare Holdings's Revenue for the
six
months ended in Dec. 2025 was HK$160.3 Mil. MedSci Healthcare Holdings's average Accounts Receivable for the
six
months ended in Dec. 2025 was HK$39.9 Mil.
Hence, MedSci Healthcare Holdings's Receivables Turnover for the
six
months ended in Dec. 2025 was 4.02.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
MedSci Healthcare Holdings Receivables Turnover Related Terms
MedSci Healthcare Holdings Receivables Turnover Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02415 vs VEEV, BTSG, TEM: Receivables Turnover Comparison
For the Health Information Services subindustry, MedSci Healthcare Holdings's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MedSci Healthcare Holdings Receivables Turnover vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MedSci Healthcare Holdings's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where MedSci Healthcare Holdings's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MedSci Healthcare Holdings (HKSE:02415) has a Receivables Turnover of 4.02 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on MedSci Healthcare Holdings and its competitors. According to the industry distribution chart, MedSci Healthcare Holdings ranks #337 out of 660 companies in the Healthcare Providers & Services industry, placing it in the top 51.1%.
Is MedSci Healthcare Holdings' Receivables Turnover too high?
MedSci Healthcare Holdings' current Receivables Turnover is 4.02. The Healthcare Providers & Services industry median Receivables Turnover is 7.97. MedSci Healthcare Holdings' value of 4.02 is 49.5% below this industry median. Based on the distribution chart, MedSci Healthcare Holdings ranks #337 out of 660 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, MedSci Healthcare Holdings has a GF Score™ of 75/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MedSci Healthcare Holdings' Receivables Turnover compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MedSci Healthcare Holdings ranks #337 out of 660 companies for Receivables Turnover. This places MedSci Healthcare Holdings in the lower half of its industry. The industry median Receivables Turnover is 7.97. MedSci Healthcare Holdings' value of 4.02 is 49.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.97, based on 660 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MedSci Healthcare Holdings's current Receivables Turnover of 4.02 is 49.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on MedSci Healthcare Holdings and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedSci Healthcare Holdings's current Receivables Turnover is 4.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedSci Healthcare Holdings stock overvalued right now?
Based on GuruFocus' analysis, MedSci Healthcare Holdings (HKSE:02415) is currently considered Possible Value Trap. The stock's GF Value™ is HK$1.43, compared to a current price of HK$0.76 — trading 46.9% below its estimated fair value. The current Receivables Turnover is 4.02 and 49.5% below the Healthcare Providers & Services industry median of 7.97. MedSci Healthcare Holdings' overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For MedSci Healthcare Holdings (HKSE:02415), the current Receivables Turnover is 4.02 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MedSci Healthcare Holdings (HKSE:02415) Overvalued in 2026?
Based on GuruFocus' analysis, MedSci Healthcare Holdings stock appears to be undervalued.
The current stock price of HK$0.76 is trading 46.9% below its estimated GF Value™ of HK$1.43.
GuruFocus considers MedSci Healthcare Holdings to be Possible Value Trap.
Key valuation signals for HKSE:02415:
Receivables Turnover: 4.02
GF Value™: HK$1.43 vs. price of HK$0.76 (46.9% below fair value)
Industry Position: 49.5% below the Healthcare Providers & Services median (#337 of 660)
No single metric tells the full story. See the HKSE:02415 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MedSci Healthcare Holdings Ltd is an investment holding company. It operates online professional physician platforms in China. The principal activities of the company are the provision of physician platform solutions, precision omni-channel marketing solutions, and real-world study solutions in the People's Republic of China.
75GF Score
Get the complete analysis for HKSE:02415
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02415 has been successfully added to your 
